Anaphylaxis: acute treatment and management.

Area of Science:

• Allergy and Immunology
• Emergency Medicine
• Clinical Pharmacology

Background:

• Anaphylaxis is a severe, life-threatening allergic reaction with rapid onset.
• Effective management necessitates practical knowledge for both healthcare providers and patients.
• Distinguishing acute treatment from long-term patient management is essential.

Purpose of the Study:

• To outline current best practices for the acute management of anaphylaxis.
• To emphasize the importance of early diagnosis and appropriate pharmacologic interventions.
• To provide guidance on patient observation, risk assessment, and long-term care strategies.

Main Methods:

• Clinical assessment for early diagnosis, differentiating from other conditions.
• Grading treatment intensity based on symptom severity.
• Pharmacologic interventions including epinephrine, corticosteroids, and antihistamines.
• Volume replacement strategies for shock management.
• Patient observation protocols and risk factor identification.

Main Results:

• Early diagnosis is clinical; laboratory tests are not useful acutely.
• Intramuscular epinephrine is the primary treatment; intravenous use is reserved for severe cases.
• Glucocorticosteroids may prevent protracted reactions but are not for acute treatment.
• Volume replacement with crystalloids or colloids is critical, especially in shock.
• Observation for 4-10 hours is recommended, with specific considerations for high-risk patients.

Conclusions:

• Anaphylaxis management hinges on prompt recognition and administration of epinephrine.
• Risk stratification and patient education, including epinephrine autoinjector use, are vital.
• Long-term management involves allergy diagnosis, potential immunotherapy, and comprehensive patient training.